NOxBOXi Nitric Oxide Systems Recalled
The recall was issued due to a misalignment of the check valve in the device’s manifold, which may cause the manifold to fail and interrupt therapy to neonates.
Tag: congenital heart condition
NOxBOXi Nitric Oxide Systems Recalled
The recall was issued due to a misalignment of the check valve in the device’s manifold, which may cause the manifold to fail and interrupt therapy to neonates.
Read More
FDA Approves First Device to Treat Congenital Heart Disease
The US FDA has approved Medtronic’s Harmony Transcatheter Pulmonary Valve (TPV) System, the first in the world nonsurgical heart valve to treat pediatric and adult patients with a native or surgically-repaired right ventricular outflow tract.
Read More
Pulse Oximetry Provides Higher Screening Sensitivity for CCHD in Newborns
Pulse oximetry-based critical congenital heart disease screening using Masimo SET had higher CCHD screening sensitivity than physical exam.
Read More
Caffeine May Prevent PGE1 Respiratory Disorders
Caffeine may prevent prostaglandin E1 (PGE1) induced respiratory complications in infants treated for congenital heart defects.
Read MorePulmonary Arterial Hypertension Affects 3% of CHD Patients
Pulmonary arterial hypertension (PAH) affects just over 3% of individuals with congenital heart disease (CHD), according to nationwide data from the Netherlands.
Read More
Capnography: A Better Way?
Capnography and capnometry are valuable tools for many applications when used in conjunction with other clinical data.
Read More